These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 11911407

  • 1. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.
    Zhao WL, Chen SJ, Shen Y, Xu L, Cai X, Chen GQ, Shen ZX, Chen Z, Wang ZY.
    Leuk Lymphoma; 2001; 42(6):1265-73. PubMed ID: 11911407
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY, Yang CH, Chen YC.
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [Abstract] [Full Text] [Related]

  • 3. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
    Chen Z, Chen GQ, Shen ZX, Chen SJ, Wang ZY.
    Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
    [Abstract] [Full Text] [Related]

  • 4. Arsenic trioxide, a therapeutic agent for APL.
    Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ, Chen Z.
    Oncogene; 2001 Oct 29; 20(49):7146-53. PubMed ID: 11704843
    [Abstract] [Full Text] [Related]

  • 5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.
    Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY.
    Blood; 1997 May 01; 89(9):3354-60. PubMed ID: 9129042
    [Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
    Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH.
    J Natl Cancer Inst; 1998 Jan 21; 90(2):124-33. PubMed ID: 9450572
    [Abstract] [Full Text] [Related]

  • 7. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.
    Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, Li JM, Zeng XY, Yang RR, Yuan MM, Ren MY, Gu FY, Cao Q, Gu BW, Su XY, Chen GQ, Xiong SM, Zhang TD, Waxman S, Wang ZY, Chen Z, Hu J, Shen ZX, Chen SJ.
    Blood; 1999 Nov 15; 94(10):3315-24. PubMed ID: 10552940
    [Abstract] [Full Text] [Related]

  • 8. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ.
    Leukemia; 2000 Feb 15; 14(2):262-70. PubMed ID: 10673743
    [Abstract] [Full Text] [Related]

  • 9. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
    Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z.
    Blood; 1997 May 01; 89(9):3345-53. PubMed ID: 9129041
    [Abstract] [Full Text] [Related]

  • 10. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A, Kizaki M, Kawamura C, Matsushita H, Fukuchi Y, Umezawa A, Yamada T, Hata J, Hozumi N, Yamato K, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2001 Aug 01; 15(8):1176-84. PubMed ID: 11480559
    [Abstract] [Full Text] [Related]

  • 11. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia.
    Wang ZY, Chen Z.
    Lancet Oncol; 2000 Oct 01; 1():101-6. PubMed ID: 11905660
    [Abstract] [Full Text] [Related]

  • 12. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies.
    Chou WC, Dang CV.
    Curr Opin Hematol; 2005 Jan 01; 12(1):1-6. PubMed ID: 15604884
    [Abstract] [Full Text] [Related]

  • 13. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
    Rojewski MT, Körper S, Schrezenmeier H.
    Leuk Lymphoma; 2004 Dec 01; 45(12):2387-401. PubMed ID: 15621751
    [Abstract] [Full Text] [Related]

  • 14. Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis.
    Chen Z, Wang ZY, Chen SJ.
    Pharmacol Ther; 1997 Dec 01; 76(1-3):141-9. PubMed ID: 9535176
    [Abstract] [Full Text] [Related]

  • 15. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
    Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z.
    Blood; 1996 Aug 01; 88(3):1052-61. PubMed ID: 8704214
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.
    Chen Z, Zhao WL, Shen ZX, Li JM, Chen SJ, Zhu J, Lallemand-Breittenbach V, Zhou J, Guillemin MC, Vitoux D, de Thé H.
    Curr Top Microbiol Immunol; 2007 Aug 01; 313():129-44. PubMed ID: 17217042
    [Abstract] [Full Text] [Related]

  • 17. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
    Jing Y.
    Leuk Lymphoma; 2004 Apr 01; 45(4):639-48. PubMed ID: 15160934
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K, Kizaki M, Muto A, Fukuchi Y, Umezawa A, Yamato K, Nishihara T, Hata J, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2000 Mar 01; 14(3):431-8. PubMed ID: 10720138
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide: acute promyelocytic leukemia and beyond.
    Bachleitner-Hofmann T, Kees M, Gisslinger H.
    Leuk Lymphoma; 2002 Aug 01; 43(8):1535-40. PubMed ID: 12400595
    [Abstract] [Full Text] [Related]

  • 20. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG, Ruthardt M.
    Mol Cell Biol; 1999 Jul 01; 19(7):5170-8. PubMed ID: 10373566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.